JPH01261315A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPH01261315A JPH01261315A JP8798488A JP8798488A JPH01261315A JP H01261315 A JPH01261315 A JP H01261315A JP 8798488 A JP8798488 A JP 8798488A JP 8798488 A JP8798488 A JP 8798488A JP H01261315 A JPH01261315 A JP H01261315A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- far infrared
- infrared ray
- effects
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 20
- 239000000919 ceramic Substances 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 9
- 230000005670 electromagnetic radiation Effects 0.000 claims description 5
- 210000003491 skin Anatomy 0.000 abstract description 49
- 230000000694 effects Effects 0.000 abstract description 20
- 230000005855 radiation Effects 0.000 abstract description 12
- 229910052845 zircon Inorganic materials 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 abstract description 9
- 230000007306 turnover Effects 0.000 abstract description 9
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 abstract description 9
- 238000002156 mixing Methods 0.000 abstract description 7
- 229910052878 cordierite Inorganic materials 0.000 abstract description 5
- JSKIRARMQDRGJZ-UHFFFAOYSA-N dimagnesium dioxido-bis[(1-oxido-3-oxo-2,4,6,8,9-pentaoxa-1,3-disila-5,7-dialuminabicyclo[3.3.1]nonan-7-yl)oxy]silane Chemical compound [Mg++].[Mg++].[O-][Si]([O-])(O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2)O[Al]1O[Al]2O[Si](=O)O[Si]([O-])(O1)O2 JSKIRARMQDRGJZ-UHFFFAOYSA-N 0.000 abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 210000004927 skin cell Anatomy 0.000 abstract description 4
- 238000004040 coloring Methods 0.000 abstract description 3
- 102000011782 Keratins Human genes 0.000 abstract description 2
- 108010076876 Keratins Proteins 0.000 abstract description 2
- 230000032683 aging Effects 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000003405 preventing effect Effects 0.000 abstract 1
- 238000009736 wetting Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 19
- 230000003712 anti-aging effect Effects 0.000 description 14
- 239000000203 mixture Substances 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 230000009467 reduction Effects 0.000 description 10
- 239000002884 skin cream Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 230000003020 moisturizing effect Effects 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 230000008859 change Effects 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000037336 dry skin Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 238000010298 pulverizing process Methods 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000003595 spectral effect Effects 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- XBLVHTDFJBKJLG-UHFFFAOYSA-N Ethyl nicotinate Chemical compound CCOC(=O)C1=CC=CN=C1 XBLVHTDFJBKJLG-UHFFFAOYSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 206010048218 Xeroderma Diseases 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 229940105847 calamine Drugs 0.000 description 2
- 239000008338 calamine lotion Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000010304 firing Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229910052864 hemimorphite Inorganic materials 0.000 description 2
- 206010021198 ichthyosis Diseases 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 229940035049 sorbitan monooleate Drugs 0.000 description 2
- 235000011069 sorbitan monooleate Nutrition 0.000 description 2
- 239000001593 sorbitan monooleate Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003871 white petrolatum Substances 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- HVYWMOMLDIMFJA-UHFFFAOYSA-N 3-cholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 HVYWMOMLDIMFJA-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 229940064982 ethylnicotinate Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229940080236 sodium cetyl sulfate Drugs 0.000 description 1
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/26—Aluminium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(技術分野)
本発明は、遠赤外線放射性セラミックスが放射する遠赤
外線によって皮膚組織が賦活化され得る、皮膚老化防止
効果(荒肌改善効果、保湿効果、角質ターンオーバー促
進効果等)と美肌効果に優れた皮膚化粧料に関する。Detailed Description of the Invention (Technical Field) The present invention provides skin anti-aging effects (improving rough skin, moisturizing effects, promotion of keratin turnover) in which skin tissues can be activated by far infrared rays emitted by far infrared emitting ceramics. (effects, etc.) and skin cosmetics with excellent skin beautifying effects.
(従来技術)
老化皮膚では皮膚の細胞代謝機能が低下するため、従来
種々の皮膚細胞賦活成分や血行促進成分を配合した老化
防止の皮膚化粧料が堤案されている。しかし、これ等老
化防止成分を配合した従来の老化防止の皮膚化粧料は効
果が不十分であったり、刺激があったり、着色や変臭が
起こるという欠点を有していた。(Prior Art) Since cell metabolic function of the skin decreases in aging skin, anti-aging skin cosmetics containing various skin cell activating ingredients and blood circulation promoting ingredients have been proposed. However, conventional anti-aging skin cosmetics containing these anti-aging ingredients have drawbacks such as insufficient effects, irritation, coloring and odor.
又、セラミックス類は従来から皮膚化粧料に使用されて
いるが、これ等セラミックス類の有する遠赤外線放射能
に着目し、体温、外気温度、室温等に於ける遠赤外線放
射強度を測定して配合する試みはなされなかった。特に
遠赤外放射強度の強いジルコン、コージーライトについ
てはその配合が検討された事はなかった。In addition, ceramics have traditionally been used in skin cosmetics, but we focused on the far-infrared radiation that these ceramics possess, and formulated them by measuring the far-infrared radiation intensity at body temperature, outside temperature, room temperature, etc. No attempt was made to do so. In particular, the combination of zircon and cordierite, which have strong far-infrared radiation intensity, has not been studied.
(発明の開示)
本発明者らは老化防止効果を有する上記欠点を改良すべ
く鋭意研究した結果、6〜20μmの電磁波は人皮深部
まで到達し、皮膚細胞の賦活化や血行の促進効果によっ
て老化防止や美肌効果を示す事が判明した。(Disclosure of the Invention) As a result of intensive research by the present inventors to improve the above-mentioned drawbacks of anti-aging effects, the electromagnetic waves of 6 to 20 μm reach deep into the human skin, and have the effect of activating skin cells and promoting blood circulation. It has been found to have anti-aging and skin beautifying effects.
そこで、この知見をもとに種々検討した結果、波長6〜
20μmの範囲において、同一温度の黒体の電磁波放射
量を基準としたときの電磁波放射百分率が80%以上で
あるセラミックス粉体を配合してなる皮膚化粧料は皮膚
細胞が賦活化され、それらの構造を緻密化し、水分保持
機能を高め、かつ角質層のターンオーバーを促進し、乾
燥皮膚を改善し、皮膚に湿潤性(しっとり惑)、柔軟性
(滑らか感)、弾力性を与える美肌効果を有することを
見出し本発明を完成するに至った。Therefore, as a result of various studies based on this knowledge, we found that the wavelength 6~
In the range of 20 μm, skin cosmetics containing ceramic powder with an electromagnetic wave radiation percentage of 80% or more based on the electromagnetic wave radiation amount of a black body at the same temperature will activate skin cells and increase their It has a skin-beautifying effect by densifying the structure, increasing the water retention function, promoting the turnover of the stratum corneum, improving dry skin, and giving the skin moisture (moist sensation), flexibility (smoothness), and elasticity. The present invention was completed based on this discovery.
(発明の目的)
即ち本発明の目的は安全で、安定性が高く、かつ配合に
よる変臭や着色のない、荒肌改善効果、保湿効果、角質
層ターンオーバー促進効果等の皮膚老化防止効果と美肌
効果に優れた皮膚化粧料を捷供することにある。(Objective of the Invention) In other words, the object of the present invention is to provide a product that is safe, highly stable, does not cause odor or coloring due to its formulation, and has skin aging prevention effects such as improving rough skin, moisturizing effect, and promoting stratum corneum turnover. The purpose is to provide skin cosmetics with excellent skin beautifying effects.
(発明の構成)
本発明は、波長6〜20#mの範囲において、同一温度
の黒体の電磁波放射量を基準としたときの電磁波放射百
分率が80%以上であるセラミックス粉体を配合してな
る皮膚化粧料である。(Structure of the Invention) The present invention contains a ceramic powder that has an electromagnetic radiation percentage of 80% or more in the wavelength range of 6 to 20 m, based on the electromagnetic radiation amount of a black body at the same temperature. It is a skin cosmetic.
(構成の具体的な説明)
本発明におけるtm波放射百分率とは、一定温度におけ
るエネルギー放射量がブランクの法則に従う理想黒体の
エネルギー放射強度を100%とした時の、試料の同一
温度における相対エネルギー放射率の事である。試料の
電磁波放射百分率は温度によっては異ならないが、試料
が体温によってあたためられて遠赤外線を放射する事か
ら、本発明では、遠赤外線放射セラミックス粉体として
30〜70℃の温度範囲で波長6μm〜20IJmの電
磁波の放射百分率が80%以上のものを使用する。(Specific explanation of the structure) The TM wave radiation percentage in the present invention is the relative value of the sample at the same temperature, when the energy radiation intensity of an ideal black body in which the amount of energy radiation at a constant temperature follows Blank's law is taken as 100%. It is energy emissivity. Although the percentage of electromagnetic radiation of a sample does not vary depending on the temperature, since the sample emits far infrared rays when warmed by body temperature, in the present invention, as a far infrared emitting ceramic powder, it is possible to emit far infrared rays in the temperature range of 30 to 70°C with a wavelength of 6 μm to 6 μm. The radiation percentage of electromagnetic waves of 20 IJm is 80% or more.
本発明で使用する遠赤外線放射性セラミックス。Far-infrared emissive ceramics used in the present invention.
粉体は公知のマグネシウム酸化物、アルミニウム酸化物
、ジルコニウム酸化物、ケイ素酸化物、あるいは金属の
炭酸塩、粘度鉱物等を例えば下記の化学反応式に示す比
率(化学量論比)で充分均一に混合し、1000℃以上
で焼成、粉砕して得られる。たとえばコージーライト(
2Mg0・2Al* Os ’ 5SiO* )は9
ルク (3Mg0・4 S I O,・H,0)とカリ
オン(A1zo2・2SiO,・2H10)とマグネサ
イト(M g COx )とを混合し、1400℃で焼
成したものを粉砕して得られる。化学反応式で示すと次
の通りである。The powder is made of known magnesium oxide, aluminum oxide, zirconium oxide, silicon oxide, metal carbonate, clay mineral, etc., sufficiently uniformly in the ratio (stoichiometric ratio) shown in the chemical reaction formula below. It is obtained by mixing, baking at 1000°C or higher, and pulverizing. For example, cozy light (
2Mg0・2Al*Os' 5SiO*) is 9
It is obtained by mixing luc (3Mg0.4 S IO, .H,0), carrion (A1zo2.2SiO, .2H10), and magnesite (M g COx ), firing at 1400° C., and pulverizing the mixture. The chemical reaction formula is as follows.
3Mg0・4 S r Ot ・Hz O+ 8 (
A 1203・2510g ・2 H□O)+5Mg
C0,→4(2Mg0・2AN!01 ・53i0t
)+178z O+5CO□
また、ジルコン(ZrSiOa)は、ジルコニア(Zr
Oi)とシリカ(Sift)の混合、焼成、粉砕によっ
て得られる。又天然に産するジルコンをそのまま利用す
る事もできる。3Mg0・4 S r Ot ・Hz O+ 8 (
A 1203・2510g ・2H□O)+5Mg
C0,→4(2Mg0・2AN!01・53i0t
)+178z O+5CO□ Also, zircon (ZrSiOa) is zirconia (Zr
It is obtained by mixing Oi) and silica (Sift), firing and pulverizing. It is also possible to use naturally occurring zircon as it is.
本発明では、これら遠赤外線放射セラミックス粉体の内
、感触、効果の点からコージーライト、ジルコンが特に
好ましい。In the present invention, among these far-infrared emitting ceramic powders, cordierite and zircon are particularly preferred from the viewpoint of feel and effect.
本発明で使用するセラミック粉体の分光赤外線放射率曲
線は第1図〜第2図に示す通りで比較の酸化チタン(図
3)、タルク(図4)と比べて明らかに遠赤外放射能に
優れている。The spectral infrared emissivity curves of the ceramic powder used in the present invention are shown in Figures 1 and 2, and the far-infrared radiation is clearly higher than that of titanium oxide (Figure 3) and talc (Figure 4). Excellent.
試料をBruker社製のFT−IRスペクトロメータ
ーIF5−113V型にて下記の条件で測定する。The sample is measured using a Bruker FT-IR spectrometer model IF5-113V under the following conditions.
検出器 : DTGS
付属装置二発光スペクトル測定用付属装置参照試料:黒
体
測定温度:60゜
測定波長:6〜20μm
尚、上記の放射率は温度によって変わらないので、皮膚
温近辺よりも測定しゃすい60”にて測定した。Detector: DTGS Attached device 2 Attached device for emission spectrum measurement Reference sample: Black body Measurement temperature: 60° Measurement wavelength: 6 to 20 μm Note that the above emissivity does not change depending on temperature, so it is easier to measure than near skin temperature. Measured at 60".
本発明で使用するセラミック粉体の粒径は0.01〜2
0μmである。20IImよりも大きいと皮膚に異和感
を惑し0.01μmよりも小さいと化粧料中の油性基剤
を劣化させる触媒作用が強くなって好ましくない。The particle size of the ceramic powder used in the present invention is 0.01 to 2.
It is 0 μm. If it is larger than 20 IIm, it will give a strange feeling to the skin, and if it is smaller than 0.01 μm, the catalytic action that degrades the oily base in cosmetics will be strong, which is not preferable.
又その配合量は、皮膚化粧料の総量を基準として0.0
1〜20重世%(以下、wt%と略記する)の範囲が好
適である。0.01wt%未満では効果が充分に達成さ
れず、20wt%を超えてもその増加分に見合った効果
の向上は望めない。Also, the blending amount is 0.0 based on the total amount of skin cosmetics.
A range of 1 to 20 weight percent (hereinafter abbreviated as wt%) is suitable. If it is less than 0.01 wt%, the effect will not be sufficiently achieved, and if it exceeds 20 wt%, it cannot be expected that the effect will improve commensurately with the increase.
本発明の皮膚化粧料は、例えばカラミンローション、ク
リーム類、乳ン佼類、メイクアソブヘース類等に適用す
ることができる。The skin cosmetics of the present invention can be applied to, for example, calamine lotions, creams, creams, makeup assemblies, and the like.
尚、本発明の皮膚化粧料には上記成分の他に色素、香料
、防腐剤、界面活性剤、抗酸化剤、油性基剤等を本発明
の目的を達成する範囲内で適宜配合することができる。In addition to the above-mentioned ingredients, the skin cosmetics of the present invention may contain pigments, fragrances, preservatives, surfactants, antioxidants, oil bases, etc. as appropriate within the scope of achieving the purpose of the present invention. can.
以下本発明の実施例について説明する。Examples of the present invention will be described below.
実施例に示す部とは重量部を、%とは重量%を意味する
。また実施例に示す、保存安定性試験(変色、変臭の有
無)、荒肌改善効果試験、保湿効果試験、角質層ターン
オーバー改善効果試験、官能試験(刺激性、湿潤性、平
滑性、弾力性)は下記の通りである。In the examples, parts mean parts by weight, and % means weight %. In addition, the storage stability test (presence of discoloration and odor), rough skin improvement effect test, moisturizing effect test, stratum corneum turnover improvement effect test, and sensory test (irritancy, wettability, smoothness, elasticity) shown in Examples. gender) are as follows.
il+ 保存安定性試験
試料を45℃の恒温室に3ケ月間保存した後の、色及び
匂いの変化の有無を調べた。il+ Storage Stability Test Samples were stored in a constant temperature room at 45° C. for 3 months, and then the presence or absence of changes in color and odor was examined.
+21 i肌改善効果試験
塗布効果を調べた。被験者の左側下脚試験部位に1日1
回約1gの試料を塗布し、試験開始前及び終了後の皮膚
の状態を下記の判定基準により判定した。右側下脚は試
料を塗布せず対照とした。+21 i Skin improvement effect test The application effect was investigated. 1 day per day on the subject's left lower leg test site.
Approximately 1 g of the sample was applied each time, and the condition of the skin before and after the start of the test was judged according to the following criteria. No sample was applied to the right lower leg, which served as a control.
皮膚乾燥度の判定基準
−二正常
± :軽微乾燥、落屑なし
+ :乾燥、落屑軽度
++8乾燥、落屑中等度
十十+】乾燥、落屑顕著
試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば、+−一
、+十−±)を有効、1段階改善された場合をやや有効
、変化がなかった場合を無効とした。試験結果は有効、
やや有効となった被験者の人数で示した。Judgment criteria for skin dryness - 2 Normal ±: Slight dryness, no flaking +: Mild dryness, flaking + 8: Moderate dryness, flaking 10+] Dryness, flaking noticeable The judgment results of the test site and control site before and after the test were compared. The test was considered valid if the skin dryness improved by two or more levels (for example, +-1, +1-±), slightly effective if it improved by one level, and invalid if there was no change. Test results are valid,
It is shown by the number of subjects who were somewhat effective.
(3) 保湿効果試験(TWL値低減率)前述の荒肌
改善効果試験開始前及び終了後の被験者皮膚を対象とし
て4週間連続塗布前及び塗布後のTWL値及びTWL値
の低減率(水分保持機能先進効果)を下記の如く算出し
て、保湿効果を調べた。(3) Moisturizing effect test (TWL value reduction rate) TWL value and TWL value reduction rate (moisture retention The moisturizing effect was investigated by calculating the functional advanced effect) as follows.
■TWL値
密閉した皮表上の空気の一定時間内の湿度変化を電気抵
抗にて測定する方法を用いた。■TWL value A method was used to measure the humidity change in the air above the sealed skin surface over a certain period of time using electrical resistance.
即ち、被試験者の皮表を測定用セルで密閉し、セルに強
制乾燥した空気を通気してセル内を乾燥空気で充分置換
した後、乾燥空気の通気を停止してその時点でのセル内
の相対湿度RHs(%)を求め、次いで10分間放置し
て再びセル内の相対湿度RH,。(%5を測定し、この
時の湿度変化から下記の式によりTWL値(mg/cm
” /hr)を算出した。That is, the test subject's skin surface is sealed in a measurement cell, forced dry air is vented into the cell to sufficiently replace the inside of the cell with dry air, and then the ventilation of dry air is stopped and the cell is closed at that point. Determine the relative humidity RHs (%) in the cell, then let it stand for 10 minutes and then re-calculate the relative humidity RH in the cell. (%5 is measured, and from the humidity change at this time, the TWL value (mg/cm
”/hr) was calculated.
xlOO
但し、Dt:測定温度下(t”c)での空気中の飽和水
蒸気の密度(mg/jり
V :セルの容積(ll>
S :測定面積(cm”)
■T W L 4Iiの低減率
TWL値の低減率は、試料塗布前後のT W L 4f
t、TWL、及びTWLIを下記の式に代入して算出し
た。xlOO However, Dt: Density of saturated water vapor in the air at the measurement temperature (t”c) (mg/j) V: Cell volume (ll> S: Measurement area (cm”)) ■T W L 4 Reduction of Ii The reduction rate of the TWL value is T W L 4f before and after sample application.
It was calculated by substituting t, TWL, and TWLI into the following formula.
TWL値低減率=(1−TWLm / TWLa )
X 100 (χ)TWLA :試料塗布前のT
WL値
TWLI ;試料塗布後のT W L f+龜TWL
値の低減率が20%以上の場合を「有効」、低減率が2
0%未満の場合を[無効]とした。試験結果は、20人
中の「有効」であった被験者の人数で表示した。TWL value reduction rate = (1-TWLm / TWLa)
X 100 (χ)TWLA: T before sample application
WL value TWLI; T W L f + TWL after sample application
“Valid” if the value reduction rate is 20% or more, and the reduction rate is 2
If it was less than 0%, it was defined as [invalid]. The test results are expressed as the number of subjects out of 20 who were "effective".
(4) 角質層ターンオーバー改善効果試験蛍光色素
のダンジルクロライドを白色ワセリン中に5重量%配合
した軟膏を作り、荒れ肌、乾燥皮膚及び老人性乾皮症状
を訴える中高年被験者20名の前腕部皮膚に24時間閉
塞貼付し、角質層にダンジルクロライドを浸透結合させ
る。その後、左腕の同じ部位に被験試料を、右腕に対照
として白色ワセリンを1日2回(朝・夕)塗布し、毎日
ダンジルクロライドの蛍光を調べ、その蛍光が消失する
までの日数を角質層のターンオーバー速度とした。尚、
通常のターンオーバー速度は、14〜16日であるが、
老化した皮膚では18日前後に延び、賦活された状態で
は短縮される傾向にあることが知られている。(4) Effect test on improving stratum corneum turnover An ointment containing 5% by weight of the fluorescent dye danzyl chloride in white petrolatum was prepared and tested on the forearm skin of 20 middle-aged and elderly subjects complaining of rough skin, dry skin, and senile xeroderma symptoms. The patch is applied occlusively for 24 hours to allow danzyl chloride to penetrate and bind to the stratum corneum. After that, the test sample was applied to the same part of the left arm, and white petrolatum was applied to the right arm as a control twice a day (morning and evening), and the fluorescence of danzyl chloride was checked every day, and the number of days until the fluorescence disappeared was calculated from the stratum corneum layer. The turnover rate was set as still,
The normal turnover rate is 14-16 days, but
It is known that in aged skin, the skin length increases by around 18 days, and in an activated state, it tends to be shortened.
試料塗布部のターンオーバー速度が対照部の比較して1
0%以上短縮された場合を、「有効」、5%以上の場合
を「やや有効」、5%以下、無変化、増大の場合は「無
効」とした。試験の結果は、「有効」あるいは「やや有
効」と回答した被験者の数で示した。The turnover rate of the sample application area was 1 compared to the control area.
A reduction of 0% or more is considered "effective," a reduction of 5% or more is considered "slightly effective," and a reduction of 5% or less, no change, or increase is considered "ineffective." The results of the test were expressed as the number of subjects who answered "effective" or "somewhat effective."
(5) 官能試験
荒れ肌、乾燥肌及び老人性乾皮症状等を訴える中高年女
子被験者20人が試料を1日2回(朝・り)連続3ケ月
間使用後の効果を評価した。試験結果は、皮膚の刺激性
湿潤性、平滑性、弾力性の各項目に対して、皮膚に刺激
を感じた、皮膚に潤いが生じた、皮膚が滑らかになった
、皮膚に張りが生じたと回答した人数で示した。(5) Sensory test Twenty middle-aged and elderly female subjects complaining of rough skin, dry skin, and senile xeroderma symptoms evaluated the effects after using the sample twice a day (in the morning and once again) for three consecutive months. The test results showed that the skin felt irritated, the skin felt moisturized, the skin became smooth, and the skin felt taut in terms of skin irritation, wettability, smoothness, and elasticity. Shown by number of respondents.
実施例1〜2、比較例1〜2
(0/W型スキンクリーム)
各種顔料、セラミックス類として第1表に記載の成分を
配合する他は下記組成の通り配合して各種0/W型スキ
ンクリームを調製し、試験を実施した。Examples 1 to 2, Comparative Examples 1 to 2 (0/W type skin cream) Various 0/W type skin creams were prepared by blending the following compositions except for the ingredients listed in Table 1 as various pigments and ceramics. A cream was prepared and tested.
(1)組成
原料組成 配合量(wt%)
A)第1表に示す成分 第1表に示す配合量B)流
動パラフィン 15.0ミツロウ
5.0ステアリン酸
3.0ソルビタンセスキオルエート2.0
セタノール 2.0P、O,E
ソルビタンモノオルエート(20E、0.) 5
.0
C)グリセリン 5.0メチル−
P 0.1精製水
全量を100wt%とする量
(2) jJi製法
C)成分を80℃に加熱溶解した中へA)成分を均一に
分散し、これに80℃に加熱溶解したB)成分を投入し
撹拌しつつ30℃まで冷却して各スキンクリームを調製
した。(1) Composition Raw material composition Amount (wt%) A) Ingredients shown in Table 1 Blend amount shown in Table 1 B) Liquid paraffin 15.0 Beeswax
5.0 stearic acid
3.0 Sorbitan Sesquioleate 2.0 Setanol 2.0P, O, E
Sorbitan monooleate (20E, 0.) 5
.. 0 C) Glycerin 5.0 Methyl-
P 0.1 purified water
Amount to make the total amount 100 wt% (2) jJi manufacturing method Component A) is uniformly dispersed in a mixture of component C) heated and dissolved at 80°C, and component B) heated and dissolved at 80°C is added thereto while stirring. Each skin cream was prepared by cooling to 30°C.
(3)特性
第1表に示す如く、遠赤外線をあまり放射しない酸化チ
タン、タルクを配合した比較例1.2のスキンクリーム
は、荒肌改善効果、保湿効果等の老化防止効果に劣るも
のであった。一方、ジルコン、コージライトを配合した
本発明のスキンクリームは保存安定性、老化防止効果等
に優れその差は明らかであった。(3) Characteristics As shown in Table 1, the skin creams of Comparative Examples 1 and 2 containing titanium oxide and talc, which do not emit much far-infrared rays, are inferior in anti-aging effects such as improving rough skin and moisturizing effects. there were. On the other hand, the skin cream of the present invention containing zircon and cordierite was excellent in storage stability, anti-aging effect, etc., and the difference was clear.
比較例3.4
老化防止剤として、第1表に示す配合成分を配合する外
は実施例1と同様の組成、調製方法で比較のスキンクリ
ームをi1m製した。その特性を第1表に示す、第1表
から明らかな如く、老化防止剤としてビタミンEを配合
した比較例3のスキンクリームは老化防止効果は認めら
れるものの保存安定性が悪く、又老化防止剤としてニコ
チン酸エチルを配合した比較例4のスキンクリームは皮
膚刺激を有していて好ましいものではなかった。Comparative Example 3.4 A comparative skin cream was prepared using the same composition and preparation method as in Example 1, except that the ingredients shown in Table 1 were added as anti-aging agents. Its properties are shown in Table 1.As is clear from Table 1, the skin cream of Comparative Example 3 containing vitamin E as an anti-aging agent had an anti-aging effect but had poor storage stability. The skin cream of Comparative Example 4 containing ethyl nicotinate as a skin cream had skin irritation and was not preferable.
実施例3〜8 (0/W型スキンミルク)ジルコンの配
合量を第2表の如く変化させる他は下記組成の通り配合
して各種0/W型スキンミルクを調製し、試験を実施し
た。Examples 3 to 8 (0/W type skin milk) Various 0/W type skin milks were prepared and tested using the following compositions except that the amount of zircon was varied as shown in Table 2.
(1) &tl成
原料組成 配合量(wt%)A)ジルコン
第2表に示す星B)流動パラフィン
10.0セタノール 2.
0コレステリン 1.0ソルビタンモ
ノオルエート 0.50)ソジウムセチルサルフ二
一ト 0.8精製水 全量を100wt
%とする量
(2)調製法
実施atと同様に行なう。(1) &tl Raw material composition Blend amount (wt%) A) Zircon
Star shown in Table 2 B) Liquid paraffin
10.0 Cetanol 2.
0 Cholesterin 1.0 Sorbitan monooleate 0.50) Sodium cetyl sulfate 0.8 Purified water Total amount to 100wt
Amount expressed as % (2) Preparation method carried out in the same manner as at.
(3)特性
第2表に示す如く、本発明のスキンミルクは保存安定性
老化防止効果に優れたものであった。(3) Properties As shown in Table 2, the skin milk of the present invention had excellent storage stability and anti-aging effects.
実施例9 (カラミンローシラン)
原料組成 配合量(wt%)コージーライト
1.0エチルアルコール
10.0グリセリン 3.0
精製水 86.0上記底分を均一
に混合して本発明のカラミンローションを調製した。そ
の特性を第3表に示す。Example 9 (Calamine low silane) Raw material composition Blending amount (wt%) Kojilite 1.0 Ethyl alcohol
10.0 Glycerin 3.0 Purified water 86.0 The above bottoms were uniformly mixed to prepare the calamine lotion of the present invention. Its characteristics are shown in Table 3.
第3表から明らかな如く、本発明のカラミンローション
は、保存安定性、老化防止効果に優れたものであった。As is clear from Table 3, the calamine lotion of the present invention had excellent storage stability and anti-aging effects.
(発明の効果)
以上の如く本発明は、保存安定性に優れ、また、老化防
止効果においても優れた有用なる皮膚化粧第 3
表(Effects of the Invention) As described above, the present invention provides useful skin cosmetics with excellent storage stability and anti-aging effects.
table
第1図〜第4図は各々ジルコン、コージーライト、酸化
チタン、タルクの分光赤外線放射率曲線第1図
第2図
浪長(μ祠Figures 1 to 4 show the spectral infrared emissivity curves of zircon, cordierite, titanium oxide, and talc.
Claims (1)
の電磁波放射量を基準としたときの電磁波放射百分率が
80%以上である遠赤外線放射性セラミックス粉体を配
合することを特徴とする皮膚化粧料。1) A skin cosmetic characterized by containing far-infrared emissive ceramic powder that has an electromagnetic radiation percentage of 80% or more in the wavelength range of 6 to 20 μm, based on the electromagnetic radiation amount of a black body at the same temperature. fee.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8798488A JPH01261315A (en) | 1988-04-09 | 1988-04-09 | Skin cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8798488A JPH01261315A (en) | 1988-04-09 | 1988-04-09 | Skin cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01261315A true JPH01261315A (en) | 1989-10-18 |
Family
ID=13930081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8798488A Pending JPH01261315A (en) | 1988-04-09 | 1988-04-09 | Skin cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01261315A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0317004A (en) * | 1989-06-13 | 1991-01-25 | Seven Kagaku:Kk | Skin cosmetic base |
JP2001122736A (en) * | 1999-10-25 | 2001-05-08 | World Beautech:Kk | Nail cosmetic |
KR101880654B1 (en) * | 2017-05-10 | 2018-07-20 | 최은호 | Cosmetic composition containing functional ceramic ball |
-
1988
- 1988-04-09 JP JP8798488A patent/JPH01261315A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0317004A (en) * | 1989-06-13 | 1991-01-25 | Seven Kagaku:Kk | Skin cosmetic base |
JP2001122736A (en) * | 1999-10-25 | 2001-05-08 | World Beautech:Kk | Nail cosmetic |
KR101880654B1 (en) * | 2017-05-10 | 2018-07-20 | 최은호 | Cosmetic composition containing functional ceramic ball |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3871640T2 (en) | COSMETIC COMPOSITION. | |
KR101002866B1 (en) | Water-in-oil emulsion-type cosmetic composition for blocking ultraviolet ray | |
KR20060089238A (en) | Compositions comprising odor neutralizing metal oxide silicates | |
JP3573890B2 (en) | Cosmetics | |
CN108042466A (en) | A kind of anti-inflammatory sterilization, the oral care composition of prevention and treatment dental caries | |
JPS58113118A (en) | Cosmetic | |
KR102359520B1 (en) | Cosmetic Composition Containing Mixture of Arginine, Hyaluronic Acid and Macadamia Nut Oil for Improving Moisturizing Effect of Hair | |
BR112014027027B1 (en) | cosmetic composition, cosmetic method for lightening and use of a combination | |
JP3513872B2 (en) | External preparation for skin | |
JPH0768101B2 (en) | Cosmetic composition containing polyethoxylated vitamin E | |
JPH10279466A (en) | Preparation for external use | |
JPH01261315A (en) | Skin cosmetic | |
JPS63150209A (en) | Skin cosmetic | |
JPS6218523B2 (en) | ||
JP2511820B2 (en) | Skin cosmetics | |
JPH0262812A (en) | Skin cosmetic | |
JPH0262810A (en) | Skin cosmetic | |
JPH0262811A (en) | Skin cosmetic | |
KR20090073622A (en) | Cosmetic composition comprising a rhodochrosite extract, smithsonite extract and phytosteryl derivatives as active ingredient | |
KR100786706B1 (en) | Emulsifier-free UV protecting cosmetic compositions of the oil-in-water type which has water splash appearance and a method of preparing thereof | |
KR19980053454A (en) | Stick-type pack cosmetics and preparation method thereof | |
KR20070003531A (en) | Loess gel | |
JPS60161911A (en) | Skin cosmetic | |
JPH0259505A (en) | Skin cosmetic | |
JPH0317004A (en) | Skin cosmetic base |